A new study looks at lives saved by USAID in the past and what the future without the agency will look like.
-
El Rito Media Managing Editor Adrian Hedden covers top stories each week.
-
Catch up on recent stories and interview on KRWG Public Media.
-
El Paso Matters President and CEO Bob Moore covers top stories each week.
-
KC Counts hosts a panel of experts who share information and resources available for individual and community efforts in our region.
-
The U.S. is up to 1,214 confirmed measles cases this year. Iowa has its first outbreak. Other states with active outbreaks include Arizona, Colorado, Illinois, Georgia, Kansas, Montana, New Mexico, North Dakota and Oklahoma.
-
A federal judge has blocked the Trump administration from withholding billions of dollars in transportation funds from states that don’t agree to participate in some immigration enforcement actions.
-
The district attorney’s office for Albuquerque announced the sentence Wednesday in a news release. Investigators say a truck carrying a mother and three young children was mistaken for another vehicle in the shooting as spectators left the stadium.
-
California is leading 20 state attorneys general in a lawsuit seeking to block health officials from further sharing Medicaid data and the Trump administration from using it for immigration enforcement or "population surveillance."
-
Tennessee's new laws on immigration already face court challenges. Other states are changing gun laws or imposing new restrictions on transgender people.
-
After 12 hours of deliberation, the jury told Judge Arun Subramanian that it had decided on counts related to sex trafficking and transportation to engage in prostitution but not yet on racketeering.
-
The athleisure brand is accusing Costco of selling knockoffs of several of its signature designs and offering them at a lower price under the wholesale club giant's Kirkland Signature brand.
-
When RFK Jr. announced he would cut funds from Gavi, the Vaccine Alliance, he cited "vaccine safety," referring to a 2017 study from Guinea-Bissau. We asked vaccine researchers to assess the study.